dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorFed Univ Para
dc.contributorMinist Saude
dc.creatorLeal, Mariana Ferreira [UNIFESP]
dc.creatorCalcagno, Danielle Queiroz [UNIFESP]
dc.creatorKhayat, Andre Salim
dc.creatorRaiol Silva, Tanielly Cristina
dc.creatorPereira Carneiro Muniz, Jose Augusto
dc.creatorAssumpcao, Paulo Pimentel
dc.creatorCardoso Smith, Marilia de Arruda [UNIFESP]
dc.creatorBurbano, Rommel Rodriguez
dc.date.accessioned2016-01-24T14:32:03Z
dc.date.accessioned2023-09-04T18:39:27Z
dc.date.available2016-01-24T14:32:03Z
dc.date.available2023-09-04T18:39:27Z
dc.date.created2016-01-24T14:32:03Z
dc.date.issued2013-08-01
dc.identifierClinical and Experimental Medicine. Milan: Springer-verlag Italia Srl, v. 13, n. 3, p. 221-224, 2013.
dc.identifier1591-8890
dc.identifierhttp://repositorio.unifesp.br/handle/11600/36584
dc.identifier10.1007/s10238-012-0195-4
dc.identifierWOS:000322677400009
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8617398
dc.description.abstractDespite the high incidence, the molecular events involved in intestinal-type gastric carcinogenesis remains unclear. We previously established an intestinal-type gastric carcinogenesis model in Cebus apella, a New World monkey. in the present study, we evaluated hTERT and TP53 mRNA expression, as well as their protein immunoreactivity, in normal mucosa, non-atrophic gastritis, atrophic gastritis, intestinal metaplasia, and intestinal-type gastric cancer samples of non-human primates treated with N-methyl-nitrosourea. in addition, we evaluated the number of TP53 copies in these samples. Although hTERT immunoreactivity was only detected in gastric cancer, a continuous increase of hTERT mRNA expression was observed from non-atrophic gastritis to gastric tumors. No sample presented p53 immunoreactivity. However, we also observed a continuous decrease of TP53 mRNA expression during the sequential steps of gastric carcinogenesis. Moreover, loss of TP53 copies was observed in intestinal metaplasia and gastric cancer samples. Our study highlights that hTERT and TP53 have a key role in intestinal-type gastric cancer initiation.
dc.languageeng
dc.publisherSpringer
dc.relationClinical and Experimental Medicine
dc.rightshttp://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0
dc.rightsAcesso restrito
dc.subjecthTERT
dc.subjectTP53
dc.subjectGastric carcinogenesis
dc.subjectNon-human primates
dc.subjectPrecancerous lesions
dc.subjectAnimal model
dc.titlehTERT and TP53 deregulation in intestinal-type gastric carcinogenesis in non-human primates
dc.typeCarta


Este ítem pertenece a la siguiente institución